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We would like to thank Dr. Jowsey and his co-authors for their valuable contribution to our 
recent article describing a novel approach for a quantitative risk assessment (QRA) for skin 
sensitizing plant protection products (Sanvido et al., 2018). As the authors of the letter to the 
editor correctly point out, an important component of the QRA is to determine which 
sensitization assessment factor (SAF) are to be used and what value is to be assigned to each 
of the different SAFs. SAFs take into account uncertainties when extrapolating from the 
experimental test conditions used for identifying the sensitizing potency of a given chemical to 
its actual in-use exposure conditions (Kimber et al., 2017). Dr. Jowsey and his co-authors 
emphasize in their letter to the editor that there is a key source of divergence in terms of how 
SAF values are deployed in our article and in a recent article published by Basketter and 
Safford (2016). Indeed, as we mention in the discussion section of our article, the number of 
SAFs to be assigned can be debated. The same is of course true for their assigned numerical 
values. As Basketter and Safford (2016) correctly cautioned that, “In setting these values it is 
recognised that, given the uncertainty in the supporting data, exact values cannot be derived, 
and a certain amount of expert judgement is required”.  
 
We would also like to emphasize here, as we already did in our original article, that the question 
regarding which SAF to assign, is primarily relevant for moderate skin sensitizers. To illustrate 
this, we assigned the SAF of 900 proposed by Dr. Jowsey and colleagues (based on Basketter 
and Safford (2016)) to our dataset (shown in Table 4 of our article). The QRA outcomes (i.e. 
whether additional protective measures for at least one part of the body are needed to avoid 
sensitization) were the same for four of the six products assessed. The QRA outcomes for two 
moderate skin sensitizers (i.e., products D and E) (Table 1) changed. Independently of whether 
a SAF of 900 or 7500 is assigned, the exposure to strong sensitizers exceeds the Derived 
No-Effect Levels (DNELs) (i.e., products A, B, and C). Weak sensitizers remain below the 
DNEL (i.e., product F). 
 
Our intention was to propose a novel approach for QRA of skin sensitizing plant protection 
products (PPPs) because such an approach is currently lacking. Within this remit, we followed 
the classical approach to QRA for skin sensitizing chemicals advocated by Kimber et al. (2017), 
which incorporates the following features: 
 
1. A no effect level is derived from the predictive toxicology work 
2. Appropriate safety factors are used to adjust the no effect level 
3. The adjusted level is compared with the human exposure level 
 
Our article should be regarded as a proof of concept that DNELs can be derived for skin 
sensitizing PPPs. These can subsequently be used together with an agricultural operator 
exposure model (AOEM) to predict exposure exceedance. We firmly believe that this approach 
will lead to an appropriate risk assessment for skin sensitizing PPPs and eventually reduce 
work-related skin diseases among PPP exposed workers. Nevertheless, we are fully aware that 
each newly proposed methodology needs discussions among experts and re-adjustments 
before it can be implemented to serve as a fully operational new risk assessment methodology, 
especially if to be used in a regulatory framework. Hence, the assigned total SAF of 7500 was 
never intended to be seen as the only possible SAF to be used in QRA of skin sensitizing PPPs. 
We strongly support further discussions on the selection of appropriate SAFs with the aim to 
define scientifically sound SAFs for PPPs that represent a reasonable worst-case. We therefore 
welcome the offer of Dr. Jowsey and his co-authors to further collaborate in evolving this 
approach in the field of pesticide risk assessment. 
 
Table 1 
Exposure calculation for two different SAFs of 900 and 7’500, respectively. The comparison 
shows that the outcome whether the DNEL is exceeded for at least one part of the body or not 
(i.e. % of DNEL > 100) remains the same for four of the six products assessed. The QRA differs 
only for products D and E depending on the SAF assigned.  
 
 SAF 900 
Basketter and Safford (2016) 
SAF 7’500 
Sanvido et al. (2018) 
 DNEL Exposure no PPE 
scenario [% of DNEL] 
DNEL Exposure no PPE 
scenario [% of DNEL] 
Product A 0.87 Hands 
Body 
Head 
814 
613 
22 
0.11 Hands 
Body 
Head 
6’780 
5’112 
183 
Product B 0.01 Hands 
Body 
Head 
26’183 
43’959 
1’291 
0.001 Hands 
Body 
Head 
218’195 
366’326 
10’761 
Product C 1.43 Hands 
Body 
Head 
74 
261 
6 
0.171 Hands 
Body 
Head 
619 
2’171 
54 
Product D 4.0 Hands 
Body 
Head 
8 
74 
2 
0.48 Hands 
Body 
Head 
70 
619 
13 
Product E 24.57 Hands 
Body 
Head 
17 
20 
1 
2.95 Hands 
Body 
Head 
143 
164 
5 
Product F 26.92 Hands 
Body 
Head 
1 
11 
0 
3.23 Hands 
Body 
Head 
12 
95 
2 
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